DirectoryMix Web Resources » Article Details

Microsoft BioIT Alliance Health Editors/Science Editors/Technology Editors - Read More

Date Added: June 12, 2008 07:44:04 PM
(AP:CAMBRIDGE, England--) (BUSINESS WIRE) _ Jun. 12, 2008--Linguamatics Ltd, a leader in enterprise text mining for the life science and other markets, today announced that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.

Category: Science and Technology » Life Sciences


No comments are posted yet


 
Name:*
Email:*
Website:  (optional)
Comment:*
(html and bb codes are filtered and not allowed)

Do the math:*CAPTCHA - Do The Math
 

Related Articles

PROMOTECH Opens New Literature Warehouse

LOUISVILLE, Colo., July 17, 2008 -- PROMOTECH, an inVentiv Health company and a leading provider of non-personal marketing solutions in the pharmaceutical, healthcare and life science industry, has built a new literature warehouse in Louisville, Colorado,

Brodeur Evolves Full Circle

Brodeur, an Omnicom-owned PR agency , today announced the formation of a new partnership with leading digital agencies and the three new practice areas in mobility, life sciences and clean technology.

BG Medicine gets $40 million in funding

BG Medicine Inc., a life sciences company focused on the development and commercialization of molecular diagnostics, has raised a $40 million fourth round of funding, the company said on Thursday.

Reyes: Towards the advancement of science and technology

ALL the years, the College of Natural Sciences (CNS) of Saint Louis University (SLU) has focused its efforts toward realizing its mission of advancing science and technology by developing biologists and health professionals who are competent, creative and

Accuri Cytometers Completes $13 Million Series C Financing

Accuri Cytometers Inc., a life sciences company developing revolutionary bench-top flow cytometer systems, today announced the completion of a $13 million Series C financing led by Fidelity Biosciences and Flagship Ventures.